The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

HIV

Filter Newest Oldest Showing 1-7 of 7 results
IDCM Newsfeed / VOLUME 1, ISSUE 3, DECEMBER 2019

Almost 40 Years into the HIV Epidemic: Are We Turning the Tide?

Ayşe Deniz Gökengin

Over the past 38 years following the introduction of HIV infection, which affected the lives of 75 million people, many scientific advances in prevention, diagnosis, treatment and care have been recorded, and the lives of people living with HIV (PLWH) have been transformed. Currently, life expectancy for PLWH who are diagnosed early and who initiate [...] Read More

Case Report / VOLUME 2, ISSUE 3, DECEMBER 2020

Old but Ageless Disease: Neurosyphilis with Ocular Manifestations in an HIV-Negative Patient

Süda Tekin and others

Syphilis is a sexually transmitted disease (STD) caused by Treponema pallidum . Primary and secondary syphilis increased to a rate of 5.3 cases per 100 000 in 2013 from the rate of 2.1 per 100 000 in 2000. Neurosyphilis is the most feared and severe complication of syphilis and may occur at any time after the initial infection. Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

HIV and SARS‐Cov‐2 Co-Infection: A Local Perspective

Heval Can Bilek and Aydın Deveci

In early December 2019, interstitial pneumonia of unknown origin emerged in Wuhan, the capital of China’s Hubei province. The pathogen was identified as a novel beta coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disease caused by SARS-CoV-2 was later named (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Cognitive Assessment of Young Adults Before and After Initiation of Combination Antiretroviral Therapy

Özlem Gül and others

The presence of cognitive disorders in the human immunodeficiency virus (HIV) infected individuals has been known for a long time. A complete neuropsychological evaluation method is a gold standard for diagnosing HIV-related cognitive impairment (HAND). However, such tests require specially trained personnel and specialized centers, and testing takes a long time. Montreal Cognitive (...) Read More

Review Article / VOLUME 4, ISSUE 4, DECEMBER 2022

HIV Pre-Exposure Prophylaxis in Central and Eastern Europe-Gains and Challenges in An Ever-Changing World

Deniz Gökengin

It has been more than a decade since the first evidence of oral pre-exposure prophylaxis (PrEP) in the “Iniciativa Profilaxis Pre-Exposición” (iPreEx) study, which reported 44% efficacy. Following these results, the US Food and Drug Administration (FDA) approved PrEP in 2012 as a method of prevention from HIV for individuals at high risk, and two years later, the Centers for Disease Control and Prevention (CDC) published the PrEP guidelines. Then, many other (...) Read More

Review Article / VOLUME 5, ISSUE 2, JUNE 2023

Opportunistic Infections Among Human Immunodeficiency Virus (HIV) Infected Patients in Turkey: A Systematic Review

Uğur Önal and Halis Akalın

Patients with human immunodeficiency virus (HIV) infection or AIDS are more likely to have diseases that would not usually cause illness in a person with a healthy immune system, called opportunistic infections. Although significant efforts to improve progression along the HIV care continuum, (...) Read More